Harvard hospitals host inaugural ME/CFS symposium

Researchers and physicians are gathering this weekend at Harvard’s first symposium on myalgic encephalomyelitis/chronic fatigue syndrome, or ME/CFS. Last year, Harvard and its affiliated hospitals launched a research center dedicated to studying the disease, which affects more than 200 million people globally. Today, around 30 scientists will be discussing various aspects of the disease, including how it affects the nervous, immune, and cardiovascular systems. Those with ME/CFS experience malaise and fatigue, and can eventually lose muscle function. While there are no treatments for the disease, the symposium will discuss ongoing and planned clinical trials. Tomorrow, it will be open to members of the public to discuss the latest research with scientists.